MedTrace Logo

Comprehensive Reverse Shoulder Data Collection

NCT03404778 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2025-10-30

No results posted yet for this study

Summary

This study is a multicenter, prospective, non-randomized, non-controlled clinical outcome study. The primary objective of this study is to evaluate improvement of pain score at one year for the Biomet Comprehensive Reverse Shoulder. The secondary objective is collection of long term clinical outcomes.

Conditions

  • Arthropathy of Shoulder Region
  • Grossly Deficient Rotator Cuff
  • Osteoarthritis of the Shoulder
  • Rheumatoid Arthritis Without Humeral Metaphyseal Defects
  • Post-Traumatic Arthitis

Interventions

DEVICE

Biomet Comprehensive Reverse Shoulder

Designed to eliminate the potential for scapular notching, this reverse shoulder system combines a a true locking mechanism that minimized wear and oxidative breakdown with a modular central screw for secure fixation.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-07
Primary Completion
2026-12-31
Completion
2036-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03404778 on ClinicalTrials.gov